N/A
N=56
Transversus Abdominal Plane Block at Total Laparoscopic Hysterectomy: Effect on Quality of Recovery
Pain, Postoperative · Anesthesia
Bottom Line
View on ClinicalTrials.gov: NCT01479270 ↗Enrolled (actual)
56
Serious AEs
0.0%
Results posted
Oct 2018
Primary outcome: Primary: Quality of Recovery Questionnaire (QoR-40) on Postop Day #1 or #2 — 168.0; 169.5 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- TAP Block (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- MetroHealth Medical Center
- Primary completion
- Sep 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Quality of Recovery Questionnaire (QoR-40) on Postop Day #1 or #2 |
168.0; 169.5 | — |
| SECONDARY Narcotic Use |
11.7; 11.8; 7.5; 9.0 | — |
| SECONDARY Visual Analog Scale (VAS) for Pain |
5.0; 6.0; 5.0; 5.0 | — |
| SECONDARY Intraoperative Time |
47.4; 34.5 | — |
Summary
The Transversus Abdominal Plane (TAP) block has been used with good success to decrease postoperative pain following laparatomy. If the TAP block provides any improvement in the quality of recovery following laparoscopic hysterectomy, it could decrease the need for postoperative narcotics and allow for more outpatient hysterectomy procedures.
Eligibility Criteria
Inclusion Criteria
- Any patient undergoing laparoscopic hysterectomy
- Age ranges 18-80
- Reading literacy
- English speaking
- Able to give informed consent
Exclusion Criteria
- History of relevant drug allergy
- Chronic opioid users who may have tolerance to pain medications
- Inability to understand written consent forms or give consent
- Age less than 18 or over 80
- Any conversion to open surgery
Data sourced from ClinicalTrials.gov (NCT01479270). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.